Michael Morris
MD
Chief, Prostate Cancer Section
👥Biography 个人简介
Michael Morris is a leader in prostate cancer theranostics who served as co-principal investigator of the landmark VISION trial establishing Lu-177-PSMA-617 as standard of care for mCRPC. His work has been transformative in bringing radioligand therapy into mainstream prostate cancer treatment. He continues to advance next-generation PSMA-targeted therapeutics and combination strategies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Michael Morris 的研究动态
Follow Michael Morris's research updates
留下邮箱，当我们发布与 Michael Morris（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment